Company: LRHC
Filing Date: 2025-03-07
Form Type: DEF 14C
Source: 0001213900-25-021334
Chunk: 6

Company: La Rosa Holdings Corp.
Filing Date: 2025-03-07
Form: DEF 14C
Chunk 6
---
Commission”
or “SEC”) an information statement with respect thereto as promptly as practicable after the Closing Date but prior to the
Stockholder Meeting Deadline (or, if such filing is delayed by a court or regulatory agency, in no event later than ninety (90) calendar
days after the Closing Date). This Information Statement is being provided to stockholders in satisfaction of the latter requirement.

On February 4, 2025, the Majority Stockholders, who hold approximately
52.7% of the votes of our outstanding voting stock as of the Record Date, provided the Stockholder Approvals (as defined below) under
the signed Majority Stockholders Consent. The Majority Stockholders Consent provides the affirmative stockholder approval required under
the Securities Purchase Agreement (the “Stockholder Approval”) of: (i) the issuance of the Initial Note, the Incremental Warrants
and Incremental Notes, all Interest Shares and all of the Conversion Shares and Incremental Conversion Shares in excess of 19.99% (without
regard to any limitation on conversion or exercise thereof) of the Company’s issued and outstanding Common Stock at a price less
than the minimum price required by The Nasdaq Stock Market LLC (“Nasdaq”) in compliance with its 20% Rule (as defined below);
(ii) authorization to complete a reverse split of our Common Stock; and (iii) authorization to increase the number of authorized shares
of our Common Stock to ensure that the Company has a sufficient number of authorized shares reserved for issuance to equal at least 200%
of the maximum number of shares issuable upon conversion of the Notes, as determined under the Securities Purchase Agreement.

<div align='center'>3</div>

Subject to the “Maximum Percentage” limitations described
(and defined) below, holders of outstanding Notes are entitled to convert any portion of the outstanding and unpaid Conversion Amount
(as defined below) thereof into shares of Common Stock at the Conversion Rate (as defined below). Each Incremental Warrant is exercisable,
at the option of the holder thereof, into Incremental Notes in an original principal amount up to $2,500,000 each, or up to $40,000,000
in the aggregate, for a period of seven years and six months from the Closing Date. The exercise of eight (8) of the sixteen (16) Incremental
Warrants issued to the Investor requires the prior written consent of the Company and Investor. The Company is currently listed on the
Nasdaq Capital Market and is subject to